1. Home
  2. ALDX vs DXYZ Comparison

ALDX vs DXYZ Comparison

Compare ALDX & DXYZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • DXYZ
  • Stock Information
  • Founded
  • ALDX 2004
  • DXYZ N/A
  • Country
  • ALDX United States
  • DXYZ
  • Employees
  • ALDX N/A
  • DXYZ N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • DXYZ
  • Sector
  • ALDX Health Care
  • DXYZ
  • Exchange
  • ALDX Nasdaq
  • DXYZ Nasdaq
  • Market Cap
  • ALDX 313.4M
  • DXYZ 313.1M
  • IPO Year
  • ALDX 2014
  • DXYZ 2024
  • Fundamental
  • Price
  • ALDX $5.26
  • DXYZ $25.83
  • Analyst Decision
  • ALDX Strong Buy
  • DXYZ
  • Analyst Count
  • ALDX 2
  • DXYZ 0
  • Target Price
  • ALDX $9.50
  • DXYZ N/A
  • AVG Volume (30 Days)
  • ALDX 647.5K
  • DXYZ N/A
  • Earning Date
  • ALDX 11-06-2025
  • DXYZ N/A
  • Dividend Yield
  • ALDX N/A
  • DXYZ N/A
  • EPS Growth
  • ALDX N/A
  • DXYZ N/A
  • EPS
  • ALDX N/A
  • DXYZ N/A
  • Revenue
  • ALDX N/A
  • DXYZ N/A
  • Revenue This Year
  • ALDX N/A
  • DXYZ N/A
  • Revenue Next Year
  • ALDX $36.23
  • DXYZ N/A
  • P/E Ratio
  • ALDX N/A
  • DXYZ N/A
  • Revenue Growth
  • ALDX N/A
  • DXYZ N/A
  • 52 Week Low
  • ALDX $1.14
  • DXYZ N/A
  • 52 Week High
  • ALDX $7.20
  • DXYZ N/A
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 48.59
  • DXYZ 45.72
  • Support Level
  • ALDX $5.13
  • DXYZ $24.58
  • Resistance Level
  • ALDX $5.79
  • DXYZ $28.55
  • Average True Range (ATR)
  • ALDX 0.28
  • DXYZ 2.30
  • MACD
  • ALDX -0.00
  • DXYZ 0.02
  • Stochastic Oscillator
  • ALDX 29.10
  • DXYZ 40.39

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About DXYZ Destiny Tech100 Inc. Common Stock

Destiny Tech100 Inc is a non-diversified, closed-end management investment company. It invests in a portfolio of what is believed to be 100 of the top venture-backed private technology companies.

Share on Social Networks: